Diffuse Gonococcal Infection (DGI) in a Patient with Treatment-Refractory Acetylcholine Receptor Antibody-Positive (AChR+) Generalized Myasthenia Gravis (gMG) Treated with Eculizumab

Patients receiving complement inhibitor, eculizumab, are at high risk for infections with encapsulated organisms such as Neisseria due to impaired opsonophagocytic activity. Impaired complement immunity may increase the risk for dissemination of asymptomatic Neisseria gonorrhoeae. Disseminated Gonoc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Case Rep Neurol Med
Autori principali: Katyal, Nakul, Nirola, Latika, Narula, Naureen, Govindarajan, Raghav
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2021
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216817/
https://ncbi.nlm.nih.gov/pubmed/34234969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/9713413
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi